New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
13:25 EDTBMY, BMY, BMY, NVO, NVO, NVOLeerink's biotech analyst holds an analyst/industry conference call
Biotech Analyst Schmidt discusses the prospects for Innate Pharma's Immuno-Oncology Drugs Lirilumab (anti-KIR) and IPH2201 (anti-NKG2A) on an Analyst/Industry conference call to be held on March 19 at 2 pm.
News For BMY;NVO From The Last 14 Days
Check below for free stories on BMY;NVO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2014
13:32 EDTBMYBristol-Myers, Pfizer announce approval of Eliquis for treatment of DVT, PE
Subscribe for More Information
August 20, 2014
08:03 EDTBMYBristol-Myers Pfizer to present new Eliquis data
Subscribe for More Information
08:02 EDTBMYBristol-Myers, Celgene enter collaboration agreement for OPDIVO, ABRAXANE
Subscribe for More Information
August 18, 2014
07:57 EDTBMYCambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.
August 11, 2014
11:58 EDTNVOMannKind rallies after inking licensing agreement with Sanofi
Subscribe for More Information
August 8, 2014
10:03 EDTBMYBristol-Myers Hodgkin lymphoma treatment granted orphan drug status
Subscribe for More Information
09:16 EDTNVONovo Nordisk management to meet with JPMorgan
Subscribe for More Information
August 7, 2014
11:02 EDTBMYBristol-Myers enters development pact with Leica Biosystem
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use